0001209191-20-044848.txt : 20200804
0001209191-20-044848.hdr.sgml : 20200804
20200804185337
ACCESSION NUMBER: 0001209191-20-044848
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200804
DATE AS OF CHANGE: 20200804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goeltz II Robert C.
CENTRAL INDEX KEY: 0001653881
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 201074880
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-03
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001653881
Goeltz II Robert C.
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
21.06
2020-08-03
4
A
0
250000
0.00
A
2030-07-31
Common Stock
250000
250000
D
The option is exercisable in 48 equal monthly installments after August 1, 2020, subject to the Reporting Person's continued service to the Company.
/s/ Carolyn Tang, Attorney-in-Fact
2020-08-04